Document is current
Any future updates will be listed below
-
Authors
Iida, Nao
Kato, Tadashi
Shiomi, Mika
Suzuki, Takashi
Yamashita, Mayu
Honda, Hirokazu
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (25K11550)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 8 September 2025
First Online: 23 October 2025
Declarations
:
: All procedures involving human participants were performed in accordance with the ethical standards of the institutional committee at which the studies were conducted (IRB approval no. 2024–189-A) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from the study participants via an opt-out procedure.
: T.K. received lecture fees from Terumo Corporation, Novartis Pharmaceuticals, and Kissei Pharmaceutical. H.H. received consulting fees from Astellas Pharma, Kyowa Kirin, Torii Pharmaceutical, Bayer Yakuhin, and Mitsubishi Tanabe Pharma and lecture fees from Astellas Pharma, Chugai Pharmaceutical, Kyowa Kirin, Torii Pharmaceutical, Bayer Yakuhin, Kissei Pharmaceutical, and Mitsubishi Tanabe Pharma.
